Entering text into the input field will update the search result below

Finch Therapeutics GAAP EPS of -$0.52, revenue of $0.35M

May 16, 2022 9:39 AM ETFinch Therapeutics Group, Inc. (FNCH) StockBy: Mary Christine Joy, SA News Editor
  • Finch Therapeutics press release (NASDAQ:FNCH): Q1 GAAP EPS of -$0.52.
  • Revenue of $0.35M.
  • Susan Graf appointed board chair and Howard Franklin chief medical officer.
  • Shares +3.59%.

Recommended For You

More Trending News

About FNCH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
FNCH--
Finch Therapeutics Group, Inc.